Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...